ELUVIA
Total Payments
$1.4M
Transactions
12,746
Doctors
4,973
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $153,650 | 2,201 | 1,381 |
| 2023 | $254,847 | 3,133 | 1,727 |
| 2022 | $158,312 | 2,434 | 1,294 |
| 2021 | $243,132 | 1,780 | 1,036 |
| 2020 | $289,918 | 1,093 | 653 |
| 2019 | $274,238 | 2,036 | 1,197 |
| 2018 | $1,913 | 69 | 52 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $454,228 | 12,459 | 33.0% |
| Unspecified | $447,413 | 10 | 32.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348,900 | 129 | 25.4% |
| Space rental or facility fees (teaching hospital only) | $58,268 | 1 | 4.2% |
| Travel and Lodging | $39,726 | 126 | 2.9% |
| Consulting Fee | $27,050 | 20 | 2.0% |
| Grant | $425.00 | 1 | 0.0% |
Payments by Type
General
$928,597
12,736 transactions
Research
$447,413
10 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SAFE PAD | BOSTON SCIENTIFIC CORPORATION | $120,009 | 0 |
| SAFE PAD | Boston Scientific Corporation | $120,009 | 0 |
| Clinical Data and Value Proposition for Eluvia Ranger Rotablator and IVUS Using the Vascular Outcomes Collaborative | BOSTON SCIENTIFIC CORPORATION | $93,000 | 0 |
| Thermal Imaging in Peripheral Arterial Disease to Determine Efficacy of Endovascular Revascularization | Boston Scientific Corporation | $75,095 | 0 |
| Pan industry meta analysis of mortality rates in patients treated for femoropopliteal disease with paclitaxel coated devices | Boston Scientific Corporation | $25,000 | 0 |
| Panindustry metaanalysis of mortality rates in patients treated for femoropopliteal disease with paclitaxelcoated devices | BOSTON SCIENTIFIC CORPORATION | $14,300 | 0 |
Top Doctors Receiving Payments for ELUVIA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $509,130 | 81 |
| , M.D | Vascular Surgery | Buffalo, NY | $23,955 | 23 |
| , M.D | Interventional Cardiology | Sebring, FL | $20,499 | 21 |
| , M.D | Internal Medicine | Lubbock, TX | $16,221 | 10 |
| , MD | Vascular Surgery | Boston, MA | $15,762 | 6 |
| , MD | Vascular Surgery | Albuquerque, NM | $13,614 | 34 |
| , M.D | Internal Medicine | Absecon, NJ | $13,548 | 19 |
| , M.D | Vascular Surgery | Houston, TX | $11,791 | 9 |
| , MD | Vascular Surgery | San Francisco, CA | $11,403 | 12 |
| , M.D | Nuclear Cardiology | New Brunswick, NJ | $11,010 | 24 |
| , MD | Internal Medicine | Boynton Beach, FL | $10,607 | 10 |
| , MD | Diagnostic Radiology | New York, NY | $10,561 | 6 |
| , M.D | Internal Medicine | Raleigh, NC | $10,291 | 7 |
| , M.D | Interventional Cardiology | Wynnewood, PA | $10,161 | 13 |
| , M.D | Vascular & Interventional Radiology | Albany, NY | $10,082 | 138 |
| , M.D | Cardiovascular Disease | Aurora, CO | $9,954 | 18 |
| , MD | Surgery | Charlotte, NC | $9,679 | 6 |
| , MD | Diagnostic Radiology | Gainesville, FL | $9,140 | 7 |
| , MD | Cardiovascular Disease | Dallas, TX | $8,965 | 16 |
| , MD | Vascular Surgery | Charlotte, NC | $8,880 | 9 |
| , MD | Diagnostic Radiology | Sacramento, CA | $8,298 | 9 |
| , M.D | Student in an Organized Health Care Education/Training Program | New York, NY | $8,153 | 6 |
| , MD, MSC | Cardiovascular Disease | Boston, MA | $7,455 | 9 |
| , M.D | Cardiovascular Disease | Jonesboro, AR | $7,192 | 32 |
| , MD | Internal Medicine | New Haven, CT | $7,187 | 4 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $1.1M
- BOSTON SCIENTIFIC CORPORATION $312,293
Product Information
- Type Device
- Total Payments $1.4M
- Total Doctors 4,973
- Transactions 12,746
About ELUVIA
ELUVIA is a device associated with $1.4M in payments to 4,973 healthcare providers, recorded across 12,746 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2018 to 2024. In 2024, $153,650 was paid across 2,201 transactions to 1,381 doctors.
The most common payment nature for ELUVIA is "Food and Beverage" ($454,228, 33.0% of total).
ELUVIA is associated with 6 research studies, including "SAFE PAD" ($120,009).